<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34241798</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS.</ArticleTitle><Pagination><StartPage>1499</StartPage><EndPage>1509</EndPage><MedlinePgn>1499-1509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-021-01743-w</ELocationID><Abstract><AbstractText>Skeletal muscle pathology is thought to have an important role in the onset and/or progression of amyotrophic lateral sclerosis (ALS), which is a neurodegenerative disorder characterized by progressive muscle weakness. Since miRNAs are recognized as important regulatory factors of essential biological processes, we aimed to identify differentially expressed miRNAs in the skeletal muscle of sporadic ALS patients through the combination of molecular-omic technologies and bioinformatic tools. We analyzed the miRnome profiles of skeletal muscle biopsies acquired from ten sALS patients and five controls with Affymetrix GeneChip miRNA 4.0 Array. To find out differentially expressed miRNAs in patients, data were analyzed by The Institute for Genomic Research-Multi Experiment Viewer (MeV) and miRNAs whose expression difference were statistically significant were identified as candidates. The potential target genes of these miRNAs were predicted by miRWalk 2.0 and were functionally enriched by gene ontology (GO) analysis. The expression level of priority candidates was validated by quantitative real-time PCR (qRT-PCR) analysis. We identified ten differentially expressed miRNAs in patients with a fold change threshold&#x2009;&#x2265;&#x2009;2.0, FDR&#x2009;=&#x2009;0. We identified ten differentially expressed miRNAs in patients with a fold change threshold&#x2009;&#x2265;&#x2009;2.0, FDR&#x2009;=&#x2009;0. Nine out of the ten miRNAs were found to be related to top three enriched ALS-related terms. Based on the qRT-PCR validation of candidate miRNAs, patients were separated into two groups: those with upregulated miR-4429 and miR-1825 expression and those with downregulated miR-638 expression. The different muscle-specific miRNA profiles in sALS patients may indicate the involvement of etiologic heterogeneity, which may allow the development of novel therapeutic strategies.</AbstractText><CopyrightInformation>&#xa9; 2021. Belgian Neurological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aksu-Menges</LastName><ForeName>Evrim</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7633-8898</Identifier><AffiliationInfo><Affiliation>Department of Medical Biology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balci-Hayta</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1780-2988</Identifier><AffiliationInfo><Affiliation>Department of Medical Biology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekircan-Kurt</LastName><ForeName>Can Ebru</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-2355-6979</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, 06100, Sihhiye, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydinoglu</LastName><ForeName>Ayse Tulay</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0001-7190-1947</Identifier><AffiliationInfo><Affiliation>Department of Medical Biology, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdem-Ozdamar</LastName><ForeName>Sevim</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9348-6457</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, 06100, Sihhiye, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ersin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8418-2961</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, 06100, Sihhiye, Ankara, Turkey. ersintan@superonline.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C572154">MIRN638 microRNA, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatics analysis</Keyword><Keyword MajorTopicYN="N">Skeletal muscle</Keyword><Keyword MajorTopicYN="N">Sporadic amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword><Keyword MajorTopicYN="N">miRNA microarray</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34241798</ArticleId><ArticleId IdType="doi">10.1007/s13760-021-01743-w</ArticleId><ArticleId IdType="pii">10.1007/s13760-021-01743-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a024117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId><ArticleId IdType="pmc">5538408</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De Aguilar JL (2016) The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol 26(2):227&#x2013;236</Citation><ArticleIdList><ArticleId IdType="pubmed">26780251</ArticleId><ArticleId IdType="pmc">8029271</ArticleId><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzsimonds RM, Poo MM (1998) Retrograde signaling in the development and modification of synapses. Physiol Rev 78(1):143&#x2013;170</Citation><ArticleIdList><ArticleId IdType="pubmed">9457171</ArticleId><ArticleId IdType="doi">10.1152/physrev.1998.78.1.143</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 8:252</Citation><ArticleIdList><ArticleId IdType="pubmed">25177267</ArticleId><ArticleId IdType="pmc">4132373</ArticleId><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522&#x2013;531</Citation><ArticleIdList><ArticleId IdType="pubmed">15211354</ArticleId><ArticleId IdType="doi">10.1038/nrg1379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103(11):4034&#x2013;4039</Citation><ArticleIdList><ArticleId IdType="pubmed">16495412</ArticleId><ArticleId IdType="pmc">1449641</ArticleId><ArticleId IdType="doi">10.1073/pnas.0510928103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson A, Linsley PS (2010) The therapeutic potential of microRNA modulation. Discov Med 9(47):311&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">20423675</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweep H, Gretz N (2015) miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 12(8):697</Citation><ArticleIdList><ArticleId IdType="pubmed">26226356</ArticleId><ArticleId IdType="doi">10.1038/nmeth.3485</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk&#x2013;database: prediction of possible miRNA binding sites by &#x201c;walking&#x201d; the genes of three genomes. J Biomed Inform 44(5):839&#x2013;847</Citation><ArticleIdList><ArticleId IdType="pubmed">21605702</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2011.05.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma&#x2019;ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44(W1):W90-97</Citation><ArticleIdList><ArticleId IdType="pubmed">27141961</ArticleId><ArticleId IdType="pmc">4987924</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Guida M, Guida M, Coppola C, De Mieri G, Cotrufo R (2012) A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508(1):35&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">22903028</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L, Baranzini M, Berardinelli MG, Lattanzi W, Monforte M, Tasca G, Conte A, Logroscino G, Michetti F, Ricci E et al (2017) Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci Rep 7(1):9538</Citation><ArticleIdList><ArticleId IdType="pubmed">28842714</ArticleId><ArticleId IdType="pmc">5573384</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-10161-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, Andersen PM, Petri S, Thal DR, Michaelis J et al (2018) Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS. Cell Mol Life Sci 75(23):4301&#x2013;4319</Citation><ArticleIdList><ArticleId IdType="pubmed">30030593</ArticleId><ArticleId IdType="doi">10.1007/s00018-018-2873-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife. https://doi.org/10.7554/eLife.05005</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.05005</ArticleId><ArticleId IdType="pubmed">26274565</ArticleId><ArticleId IdType="pmc">4566075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang LZ, Zhang JS, Gong JX, Wang YH, Zhang CL, Chen H, Fang XT (2018) Effects of microRNAs on skeletal muscle development. Gene 668:107&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pubmed">29775754</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2018.05.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Chen N (2018) Regulatory role of microRNAs in muscle atrophy during exercise intervention. Int J Mol Sci 19(2):405</Citation><ArticleIdList><ArticleId IdType="pubmed">29385720</ArticleId><ArticleId IdType="pmc">5855627</ArticleId><ArticleId IdType="doi">10.3390/ijms19020405</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander MS, Kunkel LM (2015) Skeletal muscle MicroRNAs: their diagnostic and therapeutic potential in human muscle diseases. J Neuromuscul Dis 2(1):1&#x2013;11</Citation><ArticleIdList><ArticleId IdType="pubmed">27547731</ArticleId><ArticleId IdType="pmc">4988517</ArticleId><ArticleId IdType="doi">10.3233/JND-140058</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L, Jorgensen LH, Bech RD, Frandsen U, Schroder HD (2016) Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis. Biomed Res Int 2016:5930621</Citation><ArticleIdList><ArticleId IdType="pubmed">27195289</ArticleId><ArticleId IdType="pmc">4852332</ArticleId><ArticleId IdType="doi">10.1155/2016/5930621</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, Wada S, Vergani L, Hock MB, Lamon S, Leger B, Ushida T, Cartoni R, Wadley GD, Hespel P et al (2013) Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49:107&#x2013;117</Citation><ArticleIdList><ArticleId IdType="pubmed">22975021</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade HM, de Albuquerque M, Avansini SH, de Cistiane RS, Dogini DB, Nucci A, Carvalho B, Lopes-Cendes I, Fran&#xe7;a MC (2016) MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci 368:19&#x2013;24</Citation><ArticleIdList><ArticleId IdType="pubmed">27538595</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, Leonardis L, Zidar J, Koritnik B, Dolenc-Groselj L, Ristic Kovacic S, Curk T, Rogelj B (2018) Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep 8(1):5609</Citation><ArticleIdList><ArticleId IdType="pubmed">29618798</ArticleId><ArticleId IdType="pmc">5884852</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, Milo M, Hollinger HC, Walsh T, Highley JR et al (2015) Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol Appl Neurobiol 41(2):201&#x2013;226</Citation><ArticleIdList><ArticleId IdType="pubmed">24750211</ArticleId><ArticleId IdType="pmc">4329387</ArticleId><ArticleId IdType="doi">10.1111/nan.12147</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E, Baas F, Iyer A, ten Asbroek ALMA, Morello G, Cavallaro S (2015) Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis 74:359&#x2013;376</Citation><ArticleIdList><ArticleId IdType="pubmed">25500340</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh RH, Rakowicz W, Gardner R, Pestronk A (2007) Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes. Muscle Nerve 36(1):107&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pubmed">17299742</ArticleId><ArticleId IdType="doi">10.1002/mus.20755</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A, Ning K, Heath PR, Wood E, Kirby J, Fusi N, Lawrence N, Wharton SB, Ince PG, Shaw PJ (2013) Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol 125(1):95&#x2013;109</Citation><ArticleIdList><ArticleId IdType="pubmed">23143228</ArticleId><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;gan C, Vila M, Rosoklija G, Hays AP, Przedborski S (2001) Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21(17):6569&#x2013;6576</Citation><ArticleIdList><ArticleId IdType="pubmed">11517246</ArticleId><ArticleId IdType="pmc">6763092</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.21-17-06569.2001</ArticleId></ArticleIdList></Reference><Reference><Citation>Morey JS, Ryan JC, Van Dolah FM (2006) Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proc Online 8:175&#x2013;193</Citation><ArticleIdList><ArticleId IdType="doi">10.1251/bpo126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">29154141</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, Yabe I, Utsumi J, Sasaki H (2015) Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol Brain 8(1):67</Citation><ArticleIdList><ArticleId IdType="pubmed">26497046</ArticleId><ArticleId IdType="pmc">4619470</ArticleId><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercken EM, Majounie E, Ding J, Guo R, Kim J, Bernier M, Mattison J, Cookson MR, Gorospe M, de Cabo R et al (2013) Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction. Aging (Albany NY) 5(9):692&#x2013;703</Citation><ArticleIdList><ArticleId IdType="pubmed">24036467</ArticleId><ArticleId IdType="doi">10.18632/aging.100598</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren Hooten N, Fitzpatrick M, Wood WH 3rd, De S, Ejiogu N, Zhang Y, Mattison JA, Becker KG, Zonderman AB, Evans MK (2013) Age-related changes in microRNA levels in serum. Aging (Albany NY) 5(10):725&#x2013;740</Citation><ArticleIdList><ArticleId IdType="pubmed">24088671</ArticleId><ArticleId IdType="doi">10.18632/aging.100603</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano-Arroquia A, House L, Tregilgas L, Canty-Laird E, Goljanek-Whysall K (2016) The functional consequences of age-related changes in microRNA expression in skeletal muscle. Biogerontology 17(3):641&#x2013;654</Citation><ArticleIdList><ArticleId IdType="pubmed">26922183</ArticleId><ArticleId IdType="pmc">4889642</ArticleId><ArticleId IdType="doi">10.1007/s10522-016-9638-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Muller K, Zondler L, Weydt P, Mayer B, von Arnim CA, Hubers A, Dorst J, Otto M, Holzmann K et al (2015) Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 36(9):2660.e2615&#x2013;2620</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong R, Shen Z, Zheng C, Chen G, Zheng S (2016) Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia. Sci Rep 6(1):21084</Citation><ArticleIdList><ArticleId IdType="pubmed">26879603</ArticleId><ArticleId IdType="pmc">4754688</ArticleId><ArticleId IdType="doi">10.1038/srep21084</ArticleId></ArticleIdList></Reference><Reference><Citation>Jickling GC, Ander BP, Zhan X, Noblett D, Stamova B, Liu D (2014) microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS ONE 9(6):e99283</Citation><ArticleIdList><ArticleId IdType="pubmed">24911610</ArticleId><ArticleId IdType="pmc">4050059</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0099283</ArticleId></ArticleIdList></Reference><Reference><Citation>Crozat A, Aman P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363(6430):640&#x2013;644</Citation><ArticleIdList><ArticleId IdType="pubmed">8510758</ArticleId><ArticleId IdType="doi">10.1038/363640a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B (1998) TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. Embo J 17(15):4442&#x2013;4455</Citation><ArticleIdList><ArticleId IdType="pubmed">9687511</ArticleId><ArticleId IdType="pmc">1170776</ArticleId><ArticleId IdType="doi">10.1093/emboj/17.15.4442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Embree LJ, Tsai S, Hickstein DD (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273(43):27761&#x2013;27764</Citation><ArticleIdList><ArticleId IdType="pubmed">9774382</ArticleId><ArticleId IdType="doi">10.1074/jbc.273.43.27761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Sok J, Immanuel D, Yin Y, Ron D (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110(Pt 15):1741&#x2013;1750</Citation><ArticleIdList><ArticleId IdType="pubmed">9264461</ArticleId><ArticleId IdType="doi">10.1242/jcs.110.15.1741</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Muller K, Zondler L, Weydt P, Volk AE, Bozic AL, Walter M, Bonin M, Mayer B, von Arnim CA et al (2014) Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain 137(Pt 11):2938&#x2013;2950</Citation><ArticleIdList><ArticleId IdType="pubmed">25193138</ArticleId><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkaya-Ulum YZ, Balci-Peynircioglu B, Karadag O, Eroglu FK, Kalyoncu U, Kiraz S, Ertenli AI, &#xd6;zen S, Yilmaz E (2017) Alteration of the microRNA expression profile in familial Mediterranean fever patients. Clin Exp Rheumatol 108(6):90&#x2013;94</Citation></Reference><Reference><Citation>Han IB, Kim M, Lee SH, Kim JK, Kim SH, Chang JH, Teng YD (2016) Down-regulation of MicroRNA-126 in glioblastoma and its correlation with patient prognosis: a pilot study. Anticancer Res 36(12):6691&#x2013;6697</Citation><ArticleIdList><ArticleId IdType="pubmed">27920004</ArticleId><ArticleId IdType="doi">10.21873/anticanres.11280</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48(5):629&#x2013;641</Citation><ArticleIdList><ArticleId IdType="pubmed">19969067</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125(6):777&#x2013;794</Citation><ArticleIdList><ArticleId IdType="pubmed">23673820</ArticleId><ArticleId IdType="pmc">3661910</ArticleId><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E, d&#x2019;Ydewalle C, Van Den Bosch L (2010) Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol Disord Drug Targets 9(3):297&#x2013;304</Citation><ArticleIdList><ArticleId IdType="pubmed">20406181</ArticleId><ArticleId IdType="doi">10.2174/187152710791292576</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carri MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54&#x2013;66</Citation><ArticleIdList><ArticleId IdType="pubmed">21827820</ArticleId><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer-Hayes LR, Brotherton T, Glass JD (2013) Axonal degeneration in the peripheral nervous system: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp Neurol 246:6&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pubmed">23664960</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2013.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79(3):416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pubmed">23931993</ArticleId><ArticleId IdType="pmc">4411085</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>